These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study. van den Bergh WM; Mees SM; Rinkel GJ Neurosurgery; 2006 Nov; 59(5):E1152; author reply E1152. PubMed ID: 17143226 [No Abstract] [Full Text] [Related]
48. Side Effects of Long-Term Continuous Intra-arterial Nimodipine Infusion in Patients with Severe Refractory Cerebral Vasospasm after Subarachnoid Hemorrhage. Kieninger M; Flessa J; Lindenberg N; Bele S; Redel A; Schneiker A; Schuierer G; Wendl C; Graf B; Silbereisen V Neurocrit Care; 2018 Feb; 28(1):65-76. PubMed ID: 28685393 [TBL] [Abstract][Full Text] [Related]
49. Clusterin, a New Cerebrospinal Fluid Biomarker in Severe Subarachnoid Hemorrhage: A Pilot Study. Wąsik N; Sokół B; Hołysz M; Mańko W; Juszkat R; Jagodziński PP; Jankowski R World Neurosurg; 2017 Nov; 107():424-428. PubMed ID: 28803177 [TBL] [Abstract][Full Text] [Related]
50. Effect of fasudil hydrochloride, a protein kinase inhibitor, on cerebral vasospasm and delayed cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage. Zhao J; Zhou D; Guo J; Ren Z; Zhou L; Wang S; Xu B; Wang R Neurol Med Chir (Tokyo); 2006 Sep; 46(9):421-8. PubMed ID: 16998274 [TBL] [Abstract][Full Text] [Related]
51. Nitric oxide metabolites in cisternal CSF correlate with cerebral vasospasm in patients with a subarachnoid haemorrhage. Woszczyk A; Deinsberger W; Böker DK Acta Neurochir (Wien); 2003 Apr; 145(4):257-63; discussion 263-4. PubMed ID: 12748885 [TBL] [Abstract][Full Text] [Related]
52. Safety of Modified Nimodipine Dosing in Aneurysmal Subarachnoid Hemorrhage. Mahmoud L; Zullo AR; Blake C; Dai X; Thompson BB; Wendell LC; Furie KL; Reznik ME; Mahta A World Neurosurg; 2022 Feb; 158():e501-e508. PubMed ID: 34775086 [TBL] [Abstract][Full Text] [Related]
53. Serum and cerebrospinal fluid C-reactive protein levels as predictors of vasospasm in aneurysmal subarachnoid hemorrhage. Clinical article. Fountas KN; Tasiou A; Kapsalaki EZ; Paterakis KN; Grigorian AA; Lee GP; Robinson JS Neurosurg Focus; 2009 May; 26(5):E22. PubMed ID: 19409001 [TBL] [Abstract][Full Text] [Related]
54. Effects of nimodipine on cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage treated by endovascular coiling. Mijailovic M; Lukic S; Laudanovic D; Folic M; Folic N; Jankovic S Adv Clin Exp Med; 2013; 22(1):101-9. PubMed ID: 23468268 [TBL] [Abstract][Full Text] [Related]
55. Intra-arterial nimodipine for cerebral vasospasm after subarachnoid haemorrhage: Influence on clinical course and predictors of clinical outcome. Bashir A; Andresen M; Bartek J; Cortsen M; Eskesen V; Wagner A Neuroradiol J; 2016 Feb; 29(1):72-81. PubMed ID: 26825134 [TBL] [Abstract][Full Text] [Related]
56. Experience with nimodipine in aneurysmal subarachnoid haemorrhage. Popovic EA; Danks RA; Siu KH Med J Aust; 1993 Jan; 158(2):91-4. PubMed ID: 8419783 [TBL] [Abstract][Full Text] [Related]
57. Survey of clinical experience with nimodipine in patients with subarachnoid hemorrhage. Tettenborn D; Porto L; Ryman T; Strugo V; Taquoi G; Battye R Neurosurg Rev; 1987; 10(2):77-84. PubMed ID: 3329302 [TBL] [Abstract][Full Text] [Related]
58. Tirilazad for aneurysmal subarachnoid haemorrhage. Zhang S; Wang L; Liu M; Wu B Cochrane Database Syst Rev; 2010 Feb; (2):CD006778. PubMed ID: 20166088 [TBL] [Abstract][Full Text] [Related]
59. Thromboxane B2 levels in serum during continuous administration of nimodipine to patients with aneurysmal subarachnoid hemorrhage. Vinge E; Brandt L; Ljunggren B; Andersson KE Stroke; 1988 May; 19(5):644-7. PubMed ID: 3363601 [TBL] [Abstract][Full Text] [Related]
60. A non-enzymatic derived arachidonyl peroxide, 8-iso-prostaglandin F2 alpha, in cerebrospinal fluid of patients with aneurysmal subarachnoid hemorrhage participates in the pathogenesis of delayed cerebral vasospasm. Asaeda M; Sakamoto M; Kurosaki M; Tabuchi S; Kamitani H; Yokota M; Watanabe T Neurosci Lett; 2005 Jan; 373(3):222-5. PubMed ID: 15619547 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]